(Q40537694)

21 September 2017

title

Evaluation of an algorithm for switching from IV to PO therapy in clinical practice in patients with community-acquired pneumonia (English)

1 reference

21 September 2017

author name string

Menno M van der Eerden

1

1 reference

21 September 2017

Casper S de Graaff

2

1 reference

21 September 2017

Fer Vlaspolder

3

1 reference

21 September 2017

Willem Bronsveld

4

1 reference

21 September 2017

Henk M Jansen

5

1 reference

21 September 2017

Wim G Boersma

6

1 reference

21 September 2017

publication date

1 February 2004

1 reference

21 September 2017

published in

Clinical Therapeutics

1 reference

21 September 2017

volume

26

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

294-303

1 reference

Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Sequential therapy with cefuroxime followed by cefuroxime axetil in community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Parenteral-oral switch in the management of paediatric pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Intervention to discontinue parenteral antimicrobial therapy in patients hospitalized with pulmonary infections: effect on shortening patient stay

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Early Switch From Intravenous to Oral Antibiotics and Early Hospital Discharge

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Evaluation of a pneumonia practice guideline in an interventional trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

The significance of serum vs tissue levels of antibiotics in the treatment of penicillin-resistant Streptococcus pneumoniae and community-acquired pneumonia: are we looking in the wrong place?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Switch therapy: the theory and practice of early change from parenteral to non-parenteral antibiotic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

C-reactive protein. A clinical marker in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

C-reactive protein in simple community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Initial risk class and length of hospital stay in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Applying a prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Why do patients with infection remain in hospital once changed to oral antibiotics?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Observing patients after antibiotics are discontinued

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

The utility of an in-hospital observation period after discontinuing intravenous antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Early discharge of infected patients through appropriate antibiotic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990028-8

7 January 2021

10.1016/S0149-2918(04)90028-8

Identifiers

DOI

1 reference

21 September 2017

1 reference